Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation
Quality Report Card click to collapse
From Analysis:
Perivascular spaces and glymphatic clearance failure in AD
Perivascular spaces and glymphatic clearance failure in AD
Hypotheses from Same Analysis (6)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Description
Mechanistic Overview
Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation starts from the claim that modulating HCRTR1/HCRTR2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "Overview This therapeutic hypothesis proposes leveraging orexin (hypocretin) receptor modulation to enhance glymphatic system function through strengthening circadian rhythms in Alzheimer's disease. The glymphatic system—a brain-wide cerebrospinal fluid (CSF) clearance pathway most active during sleep—shows dysfunction in AD, leading to impaired clearance of toxic protein aggregates including Aβ and tau....
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
graph TD
A["Orexin neurons in
lateral hypothalamus
circadian dysregulation"] -->|"reduced signaling"| B["OX1R and OX2R
orexin receptors
decreased activation"]
B -->|"targeted modulation"| C["Orexin receptor
antagonist therapy
suvorexant/lemborexant"]
C -->|"promotes"| D["Enhanced sleep
consolidation and
NREM sleep stages"]
D -->|"activates"| E["Noradrenergic locus
coeruleus suppression
during sleep"]
E -->|"reduces"| F["Astrocytic AQP4
water channel
polarization enhanced"]
F -->|"facilitates"| G["CSF influx along
periarterial spaces
Virchow-Robin spaces"]
G -->|"drives"| H["CSF-ISF mixing
in brain parenchyma
convective flow"]
H -->|"mobilizes"| I["Amyloid-beta and
tau protein aggregates
from interstitium"]
I -->|"clearance via"| J["Perivenous drainage
pathways activated
during sleep"]
J -->|"exits to"| K["Cervical lymphatic
vessels and
systemic circulation"]
A -->|"disrupts"| L["Circadian clock genes
Per1/Per2/Clock/Bmal1
expression altered"]
L -->|"affects"| M["Glymphatic system
circadian regulation
10-20 fold variance"]
M -->|"impairs"| N["Sleep-dependent
protein aggregate
clearance capacity"]
N -->|"leads to"| O["Alzheimer pathology
progression and
neurodegeneration"]
K -->|"reduces"| P["Brain toxic protein
burden and
oxidative stress"]
P -->|"slows"| Q["Cognitive decline
and memory
impairment"]
D -->|"strengthens"| R["Circadian rhythm
restoration and
sleep architecture"]
R -->|"enhances"| M
O -->|"without treatment"| S["Progressive
neuronal loss
and dementia"]
classDef normal fill:#4fc3f7,stroke:#2196f3
classDef therapeutic fill:#81c784,stroke:#4caf50
classDef pathology fill:#ef5350,stroke:#f44336
classDef outcome fill:#ffd54f,stroke:#ff9800
classDef molecular fill:#ce93d8,stroke:#9c27b0
class A,B,F,L,M pathology
class C,D,E therapeutic
class G,H,I,J,K,P,R normal
class N,O,S pathology
class Q,S outcome
class A,B,F,I molecular
Dimension Scores
Legacy Card View — expandable citation cards
✓ Supporting Evidence 17
The conservation of sleep across all animal species suggests that sleep serves a vital function. We here report that sleep has a critical function in ensuring metabolic homeostasis. Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of β-amyloid clearance during sleep. Thus, the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.
INTRODUCTION: Prostaglandin D2 (PGD2) is a major cyclooxygenase mediator that is synthesized by activated human mast cells and other immune cells. The biological effects of PGD2 are mediated by D-prostanoid (DP1), DP2 (CRTH2) and thromboxane prostanoid (TP) receptors that are expressed on several immune and non-immune cells involved in allergic inflammation. PGD2 exerts various proinflammatory effects relevant to the pathophysiology of allergic disorders. Several selective, orally active, DP2 receptor antagonists and a small number of DP1 receptor antagonists are being developed for the treatment of allergic disorders. AREAS COVERED: The role of DP2 and DP1 receptor antagonists in the treatment of asthma and allergic rhinitis. EXPERT OPINION: Head-to-head studies that compare DP1 antagonists with the standard treatment for allergic rhinitis are necessary to verify the role of these novel drugs as mono- or combination therapies. Further clinical trials are necessary to verify whether DP
Antibodies are widely used for the detection of specific molecules such as peptides, proteins, and chemical compounds. The specificity of an antibody is therefore its most important feature. However, it is very difficult to confirm antibody specificity. Recently, we made a human protein array consisting of 19,712 kinds of recombinant human proteins produced by a wheat cell-free protein production system. Here, we demonstrate a novel protein array technology for antibody validation (CF-PA2Vtech). Full-length human cDNAs were fused to N-terminal FLAG-GST and then synthesized by the wheat cell-free system. To construct a 20 K human protein array, about 10 to 14 kinds of human proteins were mixed and captured in each well by glutathione-conjugated magnetic beads in 12 plates or one plate with 384- or 1536-well format, respectively, using a strong magnetic device. Using this protein array plate, commercially available anti-HA or anti-PD-1 antibody reacted to 13 or three human proteins, resp
PURPOSE: Due to the COVID-19 pandemic, we transitioned from an in-person bowel management program (BMP) to a telemedicine BMP. The telemedicine BMP consisted of video and/or phone call visits (remote) or a single initial in-person visit followed by remote visits (hybrid). We hypothesized that patient/family satisfaction of a telemedicine BMP would be comparable to an in-person BMP and that there would be improvement in quality of life and functional outcomes after the telemedicine BMP. METHODS: After IRB approval, demographic and outcomes data were obtained for patients who underwent the telemedicine BMP from May-October 2020. Outcomes included a parent/patient satisfaction survey, Pediatric Quality of Life Inventory (PedsQL), and parent/patient-reported outcome measures (Vancouver, Baylor, and Cleveland scores) at baseline, 1 and 3 month follow-up. Variables were compared using Chi-square or Wilcoxon-Mann-Whitney tests and a generalized mixed model was used to evaluate outcomes scores
It has been reported consistently that many female chronic pain sufferers have an attenuation of symptoms during pregnancy. Rats display increased pain tolerance during pregnancy due to an increase in opioid receptors in the spinal cord. Past studies did not consider the role of non-neuronal cells, which are now known to play an important role in chronic pain processing. Using an inflammatory (complete Freund's adjuvant) or neuropathic (spared nerve injury) model of persistent pain, we observed that young adult female mice in early pregnancy switch from a microglia-independent to a microglia-dependent pain hypersensitivity mechanism. During late pregnancy, female mice show no evidence of chronic pain whatsoever. This pregnancy-related analgesia is reversible by intrathecal administration of naloxone, suggesting an opioid-mediated mechanism; pharmacological and genetic data suggest the importance of δ-opioid receptors. We also observe that T-cell-deficient (nude and Rag1-null mutant) pr
BACKGROUND: Intimate embryo-maternal interaction is paramount for pregnancy success post-implantation. The embryo follows a specific developmental timeline starting with neural system, dependent on endogenous and decidual factors. Beyond altered genetics/epigenetics, post-natal diseases may initiate at prenatal/neonatal, post-natal period, or through a continuum. Preimplantation factor (PIF) secreted by viable embryos promotes implantation and trophoblast invasion. Synthetic PIF reverses neuroinflammation in non-pregnant models. PIF targets embryo proteins that protect against oxidative stress and protein misfolding. We report of PIF's embryotrophic role and potential to prevent developmental disorders by regulating uterine milieu at implantation and first trimester. METHODS: PIF's effect on human implantation (human endometrial stromal cells (HESC)) and first-trimester decidua cultures (FTDC) was examined, by global gene expression (Affymetrix), disease-biomarkers ranking (GeneGo), ne
During speciation-with-gene-flow, a transition from single-locus to multi-locus processes can occur, as strong coupling of multiple loci creates a barrier to gene flow. Testing predictions about such transitions with empirical data requires building upon past theoretical work and the continued development of quantitative approaches. We simulated genomes under several evolutionary scenarios of gene flow and divergent selection, extending previous work with the additions of neutral sites and coupling statistics. We used these simulations to investigate, in a preliminary way, if and how selected and neutral sites differ in the conditions they require for transitions during speciation. For the parameter combinations we explored, as the per-locus strength of selection grew and/or migration decreased, it became easier for selected sites to show divergence-and thus to rise in linkage disequilibrium (LD) with each other as a statistical consequence-farther in advance of the conditions under wh
Inherited genetic variation affects local gene expression and DNA methylation in humans. Most expression quantitative trait loci (cis-eQTLs) occur at the same genomic location as a methylation QTL (cis-meQTL), suggesting a common causal variant and shared mechanism. Using DNA and RNA from peripheral blood of Bangladeshi individuals, here we use co-localization methods to identify eQTL-meQTL pairs likely to share a causal variant. We use partial correlation and mediation analyses to identify >400 of these pairs showing evidence of a causal relationship between expression and methylation (i.e., shared mechanism) with many additional pairs we are underpowered to detect. These co-localized pairs are enriched for SNPs showing opposite associations with expression and methylation, although many SNPs affect multiple CpGs in opposite directions. This work demonstrates the pervasiveness of co-regulated expression and methylation in the human genome. Applying this approach to other types of mole
Daytime napping is a common, heritable behavior, but its genetic basis and causal relationship with cardiometabolic health remain unclear. Here, we perform a genome-wide association study of self-reported daytime napping in the UK Biobank (n = 452,633) and identify 123 loci of which 61 replicate in the 23andMe research cohort (n = 541,333). Findings include missense variants in established drug targets for sleep disorders (HCRTR1, HCRTR2), genes with roles in arousal (TRPC6, PNOC), and genes suggesting an obesity-hypersomnolence pathway (PNOC, PATJ). Association signals are concordant with accelerometer-measured daytime inactivity duration and 33 loci colocalize with loci for other sleep phenotypes. Cluster analysis identifies three distinct clusters of nap-promoting mechanisms with heterogeneous associations with cardiometabolic outcomes. Mendelian randomization shows potential causal links between more frequent daytime napping and higher blood pressure and waist circumference.
Hypocretins/orexins are rapidly emerging as functionally important neurotransmitters. Two related neuropeptides (Hcrt-1/OXA, Hcrt-2/OXB) encoded by the same precursor gene and two G-protein coupled receptors (Hcrtr1/OXR1, Hcrtr2/OXR2) are currently known. Hypocretin-containing cells are discretely localized within the perifornical hypothalamus but have widespread projections, with generally excitatory postsynaptic effects. Dense excitatory projections to all monoaminergic cell groups have been reported. A major emerging function for this system is likely to be the regulation of sleep. Alterations in hypocretin neurotransmission causes the sleep disorder narcolepsy in mice, dogs and humans. Effects on appetite, neuroendocrine and energy metabolism regulation are also suggested by other studies. Hypocretins are uniquely positioned to link sleep, appetite and neuroendocrine control, three behaviors of major importance in psychiatry. The potential role of this system in regulating the slee
Melanin-concentrating hormone (MCH) and hypocretins (Hcrt) 1 and 2 are neuropeptides synthesized in the lateral hypothalamic area by neurons that are critical in the regulation of sleep and wakefulness. Their receptors are located in the same cerebral regions, including the frontal cortex and hippocampus. The present study aimed to assess whether 96 hours of paradoxical sleep deprivation alters the functioning of the MCH and hypocretin systems. To do this, in control rats with normal sleep (CTL) and in rats that were deprived of paradoxical sleep (SD), we quantified the following parameters: 1) levels of MCH and hypocretin-1 in the cerebrospinal fluid (CSF); 2) expression of the prepro-MCH ( Pmch ) and prepro-hypocretin ( Hcrt ) genes in the hypothalamus; 3) expression of the Mchr1 and Hcrtr1 genes in the frontal cortex and hippocampus; and 4) expression of the Hcrtr2 gene in the hippocampus. These measures were performed at 6 Zeitgeber time (ZT) points of the day (ZTs: 0, 4, 8, 12, 16
Blast Exposure Induces Acute Alterations in Circadian Clock Genes in the Hypothalamus and Pineal Gland in Rats… MEDIUM▼
Blast-induced traumatic brain injury (bTBI) frequently results in sleep and circadian rhythm disturbances. We have investigated whether dysregulation of circadian rhythm after bTBI is mediated by dysregulation of clock genes in the hypothalamus and pineal gland of rats at acute (24 h) and chronic (1 month) time points post-blast. Expression of core circadian genes (Bmal1, Clock, Per1, Per2, Cry1, and Cry2) in the hypothalamus and pineal gland were quantified using quantitative real-time polymerase chain reaction. Hypocretin (Hcrt) and hypocretin receptor (Hcrtr1 and Hcrtr2) expression in the hypothalamus were also quantified along with plasma corticosterone levels. Blast-exposed rats showed a statistically significant increase in Bmal1 and decreases in Per1, Per2, and Cry2 in the pineal gland at 24 h post-blast in rats euthanized at night. In the hypothalamus, increases in Bmal1, Cry1, and Cry2 were noted along with decreases in Per1 and Per2 gene expression at 24 h post-blast in rats
Fear-associated memories and behavior are often expressed in contexts/environments distinctively different from those in which they are created. This generalization process contributes to psychological disorders, particularly PTSD. Stress-related neurocircuits in the basolateral amygdala (BLA) receive inputs from hypothalamic orexin (Orx) neurons, which mediate neuronal activity by targeting orexin 1 (Orx1R) and orexin 2 (Orx2R) receptors via opposing functions. In BLA, inhibition of Orx1R or activation of Orx2R ameliorate stress responsiveness and behavior. We discovered that most Orx1R+ cells also express CamKIIα, while a majority of Orx2R+ cells are colocalized with GAD67. Further, Orx1R gene Hcrtr1 expression was positively correlated, and Orx2R gene Hcrtr2 expression was negatively correlated, with freezing in a phenotype-dependent fashion (Escape vs Stay) in the Stress Alternatives Model (SAM). The SAM consists of 4-days of social interaction between test mice and novel larger ag
Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake transition and hemodynamic st… MODERATE▼
Pentylenetetrazol-induced seizures are exacerbated by sleep deprivation through orexin receptor-mediated hippo… MODERATE▼
✗ Opposing Evidence 11
Sleep interventions in AD trials show inconsistent cognitive benefits, possibly due to disease stage heterogen… MEDIUM▼
Glymphatic imaging methods (DTI-ALPS) have limited spatial resolution and may not capture all clearance pathwa… MEDIUM▼
Transgenic animals are an important tool in biotechnology, including the production of recombinant proteins in the milk. Traditionally, expression constructs are based on hybrid vectors bearing mammary gland specific regulatory elements from the α-casein (Csn1s1), β-casein (Csn2), whey acidic protein (WAP), or β-lactoglobulin (BLG) genes. Overexpression from the randomly integrated vectors typically provides high levels of expression, but has drawbacks due to unpredictable genome localization. CRISPR-Cas9 targeted transgene integration into the endogenous casein locus could alleviate the need for extensive animal screening to achieve high and reproducible expression levels. We decided to evaluate such a "precise" integration approach, placing the human granulocyte-macrophage colony-stimulating factor (hGMCSF) gene under control of the mouse endogenous alpha-S1-casein (Csn1s1) promoter. We designed two types of transgene integrations: a knock-in in the second exon of the Csn1s1 (INS-GM)
Individual variability in AQP4 polarization and glymphatic efficiency may limit treatment response predictabil… MEDIUM▼
Genome-wide association studies (GWASs) have facilitated the unbiased discovery of hundreds of genomic loci associated with CKD and kidney function. The vast majority of disease-associated DNA variants are noncoding. Those that are causal in CKD pathogenesis likely modulate transcription of target genes in a cell type-specific manner. To gain novel biological insights into mechanisms driving the development of CKD, the causal variants (which are usually not the most significant variant reported in a GWAS), their target genes, and causal cell types need to be identified. This functional validation requires a large number of new data sets, complex bioinformatics analyses, and experimental cellular and in vivo studies. Here, we review the basic principles and some of the current approaches being leveraged to assign functional significance to a genotype-phenotype association.
BACKGROUND: Machine learning (ML) is a growing field in medicine. This narrative review describes the current body of literature on ML for clinical decision support in infectious diseases (ID). OBJECTIVES: We aim to inform clinicians about the use of ML for diagnosis, classification, outcome prediction and antimicrobial management in ID. SOURCES: References for this review were identified through searches of MEDLINE/PubMed, EMBASE, Google Scholar, biorXiv, ACM Digital Library, arXiV and IEEE Xplore Digital Library up to July 2019. CONTENT: We found 60 unique ML-clinical decision support systems (ML-CDSS) aiming to assist ID clinicians. Overall, 37 (62%) focused on bacterial infections, 10 (17%) on viral infections, nine (15%) on tuberculosis and four (7%) on any kind of infection. Among them, 20 (33%) addressed the diagnosis of infection, 18 (30%) the prediction, early detection or stratification of sepsis, 13 (22%) the prediction of treatment response, four (7%) the prediction of anti
Glymphatic system existence and significance remain debated — some researchers argue perivascular flow is too … MODERATE▼
Orexin receptor antagonists may impair memory consolidation by disrupting REM sleep architecture, potentially … MODERATE▼
AQP4 polarization to perivascular endfeet decreases with aging, potentially limiting glymphatic enhancement in… HIGH▼
Suvorexant CSF biomarker changes were small (10-15% reduction) and may not be clinically meaningful for modify… MODERATE▼
Circadian rhythm disruption is a consequence, not cause, of AD neurodegeneration — SCN neuron loss occurs earl… MODERATE▼
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼
Novel Therapeutic Hypotheses for Perivascular Spaces and Glymphatic Clearance in AD
1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation
Description: Chronic activation of TREK-1 potassium channels in astrocytic endfeet could restore AQP4 polarization by modulating membrane lipid composition and cytoskeletal organization. TREK-1 activation increases membrane fluidity and promotes proper localization of dystrophin-associated protein complexes that anchor AQP4.
Target: KCNK2 (TREK-1 channel)
Supporting Evidence: AQP4 mislocalization is a hallmark of AD glymp
🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼
Critical Scientific Evaluation of Glymphatic Therapeutic Hypotheses
1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation
Critical Weaknesses:
- Mechanistic gap: The connection between TREK-1 activation and AQP4 polarization is speculative. TREK-1 primarily responds to mechanical stretch and lipid composition, but direct evidence linking this to dystrophin-associated protein complex organization is lacking.
- Conflicting evidence: TREK-1 activation typically leads to membrane hyperpolarization and reduced excitability, which may actually impair the calcium-de
🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼
Druggability Assessment of Glymphatic Therapeutic Hypotheses
1. Circadian Glymphatic Entrainment via Orexin Receptor Modulation
Druggability: HIGH ⭐⭐⭐⭐⭐
Target Assessment: Both HCRTR1 and HCRTR2 are well-validated GPCRs with established druggability. Crystal structures available, multiple binding sites characterized.Existing Chemical Matter:
- Suvorexant (Belsomra®) - FDA approved dual orexin receptor antagonist
- Lemborexant (Dayvigo®) - FDA approved, improved pharmacokinetics
- Daridorexant (Quviviq®) - Recently approved in EU/US
- Almorexant - Discon
⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼
Price History
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| ⚖ | Recalibrated | $0.609 | ▲ 1.6% | market_dynamics | 2026-04-13 03:33 |
| ⚖ | Recalibrated | $0.599 | ▼ 0.2% | 2026-04-12 18:34 | |
| ⚖ | Recalibrated | $0.600 | ▼ 1.8% | 2026-04-12 05:13 | |
| ⚖ | Recalibrated | $0.611 | ▼ 0.5% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.614 | ▲ 0.5% | 2026-04-10 15:53 | |
| ⚖ | Recalibrated | $0.610 | ▲ 3.5% | 2026-04-08 18:39 | |
| ⚖ | Recalibrated | $0.590 | ▲ 2.0% | 2026-04-06 04:04 | |
| ⚖ | Recalibrated | $0.578 | ▼ 0.5% | 2026-04-04 16:38 | |
| ⚖ | Recalibrated | $0.581 | ▲ 1.4% | 2026-04-04 16:02 | |
| ⚖ | Recalibrated | $0.573 | ▼ 24.7% | 2026-04-03 23:46 | |
| ⚖ | Recalibrated | $0.761 | ▲ 5.9% | market_dynamics | 2026-04-03 01:06 |
| ⚖ | Recalibrated | $0.719 | ▲ 24.2% | market_dynamics | 2026-04-03 01:06 |
| ⚖ | Recalibrated | $0.579 | ▲ 3.4% | 2026-04-02 21:55 | |
| ⚖ | Recalibrated | $0.560 | ▼ 3.2% | market_recalibrate | 2026-04-02 19:14 |
| 📄 | New Evidence | $0.579 | ▲ 3.7% | market_dynamics_seed | 2026-04-02 18:16 |
Clinical Trials (4) Relevance: 34%
Active
Completed
Total Enrolled
Highest Phase
📚 Cited Papers (46)
📓 Linked Notebooks (1)
Wiki Pages
KG Entities (41)
Dependency Graph (4 upstream, 3 downstream)
Linked Experiments (10)
Related Hypotheses
Estimated Development
🧪 Falsifiable Predictions (5)
Knowledge Subgraph (143 edges)
associated with (9)
catalyzes (1)
causes (1)
co associated with (21)
co discussed (78)
▸ Show 73 more
controls (1)
enables (1)
facilitates (1)
implicated in (7)
▸ Show 2 more
increases (1)
maintains (1)
mediates (1)
participates in (9)
promoted: Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation (1)
regulates (1)
Mechanism Pathway for HCRTR1/HCRTR2
Molecular pathway showing key causal relationships underlying this hypothesis
graph TD
HCRTR1_HCRTR2["HCRTR1/HCRTR2"] -->|promoted: Circadia| neurodegeneration["neurodegeneration"]
HCRTR1_HCRTR2_1["HCRTR1/HCRTR2"] -->|associated with| neurodegeneration_2["neurodegeneration"]
AQP1["AQP1"] -->|co associated with| HCRTR1_HCRTR2_3["HCRTR1/HCRTR2"]
GJA1["GJA1"] -->|co associated with| HCRTR1_HCRTR2_4["HCRTR1/HCRTR2"]
HCRTR1_HCRTR2_5["HCRTR1/HCRTR2"] -->|co associated with| KCNK2["KCNK2"]
HCRTR1_HCRTR2_6["HCRTR1/HCRTR2"] -->|co associated with| SDC1["SDC1"]
HCRTR1_HCRTR2_7["HCRTR1/HCRTR2"] -->|co associated with| LOX_LOXL1_4["LOX/LOXL1-4"]
HCRTR1_HCRTR2_8["HCRTR1/HCRTR2"] -->|co associated with| PDGFRB["PDGFRB"]
style HCRTR1_HCRTR2 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration fill:#ef5350,stroke:#333,color:#000
style HCRTR1_HCRTR2_1 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration_2 fill:#ef5350,stroke:#333,color:#000
style AQP1 fill:#ce93d8,stroke:#333,color:#000
style HCRTR1_HCRTR2_3 fill:#ce93d8,stroke:#333,color:#000
style GJA1 fill:#ce93d8,stroke:#333,color:#000
style HCRTR1_HCRTR2_4 fill:#ce93d8,stroke:#333,color:#000
style HCRTR1_HCRTR2_5 fill:#ce93d8,stroke:#333,color:#000
style KCNK2 fill:#ce93d8,stroke:#333,color:#000
style HCRTR1_HCRTR2_6 fill:#ce93d8,stroke:#333,color:#000
style SDC1 fill:#ce93d8,stroke:#333,color:#000
style HCRTR1_HCRTR2_7 fill:#ce93d8,stroke:#333,color:#000
style LOX_LOXL1_4 fill:#ce93d8,stroke:#333,color:#000
style HCRTR1_HCRTR2_8 fill:#ce93d8,stroke:#333,color:#000
style PDGFRB fill:#ce93d8,stroke:#333,color:#000
3D Protein Structure
🧬 HCRTR1 — PDB 6TO7 Click to expand 3D viewer
Source Analysis
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration | 2026-04-01 | completed
Community Feedback
No comments yet. Be the first to comment!